Novavax, Inc. announced a private placement to issue 6,500,000 common shares at an issue price of $13 per share for the gross proceeds of $84,500,000 on August 8, 2023. The transaction will include participation from new investor SK bioscience Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52,000 KRW | -2.62% |
|
-2.80% | -27.78% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
52,000 KRW | -2.62% | -2.80% | 2.89B | ||
14.4 USD | -4.32% | -20.75% | 2.02B | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.78% | 2.89B | |
+0.75% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+73.70% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.